Introduction
Human immunodeficiency virus (HIV-1) (Barr~-Sinoussi et al., 1983 ) is a member of the Retroviridae family and is the cause of a progressive degeneration of the immune and central nervous systems in infected individuals (Haseltine et al., 1990) . During viral maturation, the env gene product of HIV-1 (160K) is glycosylated and further processed to a 120K external envelope glycoprotein (Robey et al., 1985) and a 41K transmembrane glycoprotein (Di Marzo-Veronese et al., 1985) . These envelope glycoproteins are involved in virus-cell receptor interactions (McDougal et al., 1986) , virus-ceU fusion and syncytium formation (Lifson et al., 1986 ; Sodroski et al., 1986; Kowalski et al., 1987; Stein et al., 1987) and the induction of neutralizing antibodies (Chanh et al., 1986; Dalgleish et al., 1988; Evans et al., 1989) . Much of the effort to develop a vaccine for HIV infection has focused on the envelope glycoproteins. However, attempts to vaccinate chimpanzees with the entire molecule of gp 120 or with vaccinia virus recombinants bearing the HIV env protein did not elicit protection against subsequent virus challenge (Arthur et al., 1987 ; Hu et al., 1987; Berman et al., 1988) . Furthermore, envelope proteins of HIV-1 were reported to have potential immunopathogenic features (Chanh et al., 1988; Chir-0000-9727 © 1991 SGM mule et al., 1988 Diamond et al., 1988; Weinhold et al., 1989) ; 'molecular mimicry' between segments of envelope proteins and domains of host proteins were also reported as a possible cause of autoimmune disorders in vivo (Weigent et al., 1986; Beretta et al., 1987; Golding et al., 1989) : Therefore fragments of the virus that define critical epitopes for protective immunity, or structures that will mimic such epitopes, could be useful alternatives to existing systems as primer or stimulating immunogens.
Jerne's network theory predicts that immune responses are regulated through a series of idiotype-antiidiotype interactions (Jerne, 1974 (Jerne, , 1984 Cazenave, 1977 ; Urbain et al., 1977; Bona et al., 1981) . Idiotypes (or sets of idiotopes) are determinants expressed in the variable region of antibody molecules and lymphocyte antigen receptors. As such, they may be recognized as antigenic determinants by other immunocompetent cells. It was proposed that internal image anti-idiotypic antibodies (anti-ids) could be used as vaccines for infectious diseases (Nisonoff& Lamoyi, 1981) . Recently, several successful attempts at using anti-ids to induce a virus-specific immune response were reported (Osterhaus et al., 1988) .
In this paper we describe the production and characterization of murine monoclonal antibodies (MAbs) which recognize the transmembrane portion of the HIV-1 gpl60 envelope protein, and the development of syngeneic (anti-ids) which mimic the gpl60 antigen.
Methods
Animals. New Zealand rabbits and BALB/c mice were purchased from Charles River Laboratories. (BALB/c x Swiss Webster) F1 mice were obtained from the Animal Resources Division, Health Protection Branch (Health and Welfare, Ontario, Canada).
Cells and viruses.
HIV-1 viral lysate was purchased from Organon Teknika and recombinant envelope glycoprotein (gpl60r~¢) from MicroGeneSys. HIV-1 strains HTLV-IIIB and RF were provided by Dr Robert Gallo and were propagated in either HUT-78 (ATCC no. TIB161) or H9 (ATCC no. CRL8543) cell lines. HIV-2 strain ROD and HIV-1 strain LAV-I were provided by Dr Luc Montagnier. The LAV-1 strain was grown either in CEM cells (ATCC no. CCLll9) or in MOLT4 cells (ATCC no. CRL1582).
Production of MAbs.
Murine hybridomas were generated as previously described (Brodeur et al., 1985) . To induce the production of HIV-speciflc MAbs gp41-1 and gp41-2, mice were immunized by intraperitoneal (i.P.) inoculations of HIV-1 viral lysate and gpl60r~. The first injection consisted of 50 ~tg viral lysate emulsified in complete Freund's adjuvant (CFA); two subsequent injections of viral lysate emulsified in incomplete Freund's adjuvant (IFA) were given at 10 day intervals and three more injections of 15 p.g gp 160r~ in IFA were given at 1 month intervals. Three days before fusion, 5 ~tg gp 16%c was given intravenously. Anti-ids were derived from mice immunized with MAb gp41-1 coupled to keyhole limpet haemocyanin (KLH). Cross-linking of antibodies to KLH was done with glutaraldehyde, using a protein weight ratio of 1:1 and a final concentration of 0.05~ (v/v) glutaraldehyde (25~ aqueous solution; Sigma). The mice were inoculated i.p. with 40 ~tg MAb coupled to KLH (MAb-KLH) in CFA, two subsequent injections of MAb-KLH emulsified in IFA were given at 2 week intervals and, three days before fusion, an i.p. injection was given. Antibody-secreting hybridomas were cloned twice by limiting dilution and expanded for ascitic fluid production in pristane-treated (BALB/c x Swiss Webster) F1 mice (Brodeur & Tsang, 1986) . Isotypes were determined by ELISA using isotype-specific anti-mouse immunoglobulins (Ig) as the coating antigens (Fisherbrand; Fisher Scientific). The following murine MAbs were used as control antibodies: antiHaemophilus influenzae type b MAb Hb-2 (IgG2a) (Hamel et al., 1987) , anti-Neisseria gonorrhoeae MAb NG38 (IgG2a) (Lussier et al., 1989) and anti-ids AHb-21, AHb-22 and AHb-24, which were specific for MAb Hb-2 (Hamel & Brodeur, 1990) .
Detection ofanti-HIV MAbs. Immunofluorescence (IF) assays were done using HIV-l-infected and uninfected HUT-78 cells as described by Sandstrom et al. (1985) . Surface IF assays were done according to Kennedy et al. (1986a) with some modifications. Viable HIV-1-infected HUT-78 cells were isolated by centrifugation over a Ficollpaque (Pharmacia) solution. After two washes in phosphatebuffered saline (PBS), 25 ~tl diluted (1/500) ascitic fluid gp41-1 and gp41-2 was added to 106 cells and incubated for 30 min on ice. The cells were washed twice with PBS and incubated with fluoresceinconjugated goat anti-mouse Ig (Cappel; Organon Teknika). After washing, pellets were resuspended in PBS and the assay was then continued as described above.
ELISA for detection of anti-ids. Microtitre plates (Nunc Maxisorp; Gibco/BRL) were coated with purified gp41-1 F(ab') z fragments (0.5 ~tg/well), or with F(ab')2 fragments of a non-related MAb, in PBS for 16 h at room temperature. Non-specific sites were blocked with 0-1 ml of 1 ~ (w/v) bovine serum albumin (BSA)/PBS per well for 1 h at 37 °C. Wells were washed once with PBS containing 0.02~ (v/v) Tween-20 (PBS-T), 100 ~tl samples of culture supernatants were added and the wells were incubated at 37 °C for 1 h. After three washes with PBS-T, alkaline phosphatase-labelled anti-mouse Ig, Fc fragment-specific (Cappel; Organon Teknika), was added. After a further incubation for 1 h at 37 °C, the plates were washed three times with PBS-T and 100 ~t110~ diethanolamine pH 9.8 containing 1 mg/ml of p-nitrophenylphosphate (Sigma) was added. Absorbance (410nm) readings were done after 1 h with a Dynatech MR600 Microplate Reader (Dynatech). The results were calculated by subtracting the absorbance of wells treated with medium alone from the absorbance of experimental wells.
MAb purification and F(ab')2 fragment preparation. MAbs were purified from ascitic fluids by precipitation with 45~ (v/v) final concentration saturated ammonium sulphate in PBS, followed by chromatography on a hydroxylapatite column using a 90 mM to 210 mi sodium phosphate gradient buffer pH 6.8 (MAPS system; Bio-Rad) or DEAE-Sephacel (Pharmacia) column as previously described (Faucher et al., 1989) .
MAb F(ab')2 fragments were prepared according to Parham (1983) . Briefly, 8 mg MAb was digested with 0.8 mg pepsin and immobilized on Sepharose (Pierce Chemical), in 10 ml 0.1 M-citrate buffer pH 4.1 for 75 min at 37 °C. Digestion was stopped by adding 1.0 M-Tris-HC1 to bring the pH to 7.0 and the Sepharose beads were removed by centrifugation. Antibody solution was dialysed against PBS pH 7.3 for 16 h. Undigested antibodies were removed by affinity chromatography on protein A Sepharose (Pierce Chemical). Fragment purity was assessed by SDS-PAGE and biological activity was verified by IF assays on HIV-l-infected HUT-78 ceils.
Binding of HIV-specific MAbs to viable HIV-l-infected cells.
Binding experiments were done according to Dupuis & Bastin (1985) with some modifications. HlV-l-infected H9 cells (4 x 105) were incubated for 30 rain at 37 °C in the presence of MAbs. Cells were washed and incubated for 30 rain at 37 °C with lzsI-labelled goat anti-mouse IgG (0.1 IxCi/ml; Amersham). Ceils were separated from free radioactive ligand by centrifugation in 1.5 ml Eppendorftubes containing a layer of 0.27 M-sucrose overlaid with a 1 : 2 mixture of dinonyl phthalate and dibutyl phthalate (Sigma). Supernatants were aspirated and cell pellets were counted in a gamma counter (LKB).
Immunoblotting and radioimmunoprecipitation assays (RIPA).
Immunoblotting analyses of HIV-1 viral lysates and gpl60~ec were performed as described by Neumann et al. (1986) . Immunoblotting analysis of F(ab')2 fragments of MAb gp41-1 was done according to Towbin et al. (1979) . Anti-id binding was revealed using Fc fragmentspecific alkaline phosphatase-conjugated goat anti-mouse IgG and nitroblue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate (NBT/BCIP; AMRESCO) as substrates. R1PA was done according to Resnick et al. (1985) with the exception that HUT-78 cells were infected with a clinical isolate of HIV-1 (Eric super) and labelled with [35S]methionine and PS]cysteine.
Neutralization assays. Neutralization assays were done as reported by Robert-Guroff et al. (1985) with modifications. Briefly, ascitic fluids (1/10) were incubated at 37 °C for 1 h with an equal volume of 100 TC1D5o virus (HTLV-IIIB) and then added to 106 HUT-78 cells. Supernatants were sampled on day 13 post-infection and tested for reverse transcriptase (RT) activity.
Inhibition of binding of biotinylated HIV-specific MAbs to anti-ids.
Microtitration plates (Linbro/Titertek; Flow Laboratories) were coated with 0.5 ~g/well purified anti-id and blocked with 1 ~ (w/v) BSA in PBS for 30 rain at 37 °C. A volume of 50 p.l biotinylated gp41-1 
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53 diluted in 1 ~ (w/v) BSA in PBS was mixed with 50 p.1 purified anti-id at various concentrations and incubated for 1 h at room temperature. The mixture was then added to wells and incubated for 1 h at 37 °C. After washing, peroxidase-labelled streptavidin (BRL) was added and incubated for 30 rain at 37 °C. Absorbance was read at 450 nm using 1 mg/ml 1,2-phenylenediamine in 0.1 M-citric acid pH 4.5, containing H202 (0-012~) as substrate.
Inhibition of binding of HIV-specific MAbs to HlV-l-infected cell
lysates by anti-ids. Dot immunobinding assays were done as described by Krust et al. (1987) with some modifications. Briefly, HUT-78 cells infected with HTLV-IIIB were gamma-irradiated and washed in PBS. Lysis buffer containing 10 mM-Tris-HC1 pH 7.6, 150 mM-NaC1, l~ (v/v) Triton X-100, 2 mM-PMSF and 2~ (v/v) aprotinin (Sigma) was added to cell pellets and well mixed. Cell extracts were centrifuged at 12000 g for 10 rain and the supernatant was stored in aliquots at-80 °C; non-infected cells treated similarly were used as control antigen. Just before the assay, cell extracts were diluted 1/2 in 50 mMTris-HC1 pH 7-4, 150 mM-NaCI, 1 mM-EDTA, 1 ~ (v/v) Triton X-100, 0.1% (w/v) sodium deoxycholate, 0.1 ~ (w/v) SDS, incubated on ice for 10 rain with periodic shaking and centrifuged at 12 000 g for 15 rain at 4 °C. Cell extracts were applied to nitrocellulose membranes using a Bio-Rad Bio-Dot apparatus and the membrane was blocked with 3~ (w/v) non-fat dry milk in H20 for 16 h at 4 °C; extracts were washed three times in Tris-buffered saline (TBS) containing 20 m~-Tris-HCl pH 7.5, 500 mM-NaCI, 0.02~ (v/v) Tween-20. MAbs (50 p.1) gp41-1 (containing 1 lag/ml) and gp41-2 (containing 10 lag/ml) in PBS were incubated with equal volumes of anti-idiotype supernatants for 1 h at room temperature and then added to the membrane. Three washes were done and 0-1 laCi/ml of 125I-labelled anti-mouse IgG in 3~ BSA]PBS was added for 1 h at room temperature. The membrane was then washed four times with TBS containing 0-02~ (v/v) Tween-20, dried, exposed to X-ray film (Cronex 4; Dupont) and, after exposure for 48 h, each spot was cut and counted. Detection of anti-gp160 antibodies by ELlSA. Sera from anti-idimmunized animals and HIV-specific MAbs were tested by ELISA using 125 rig/well gpl60r~. Rabbit and mice sera were diluted 1/250 and 1/100 respectively. Inhibition of binding of rabbit sera to gp160r~-coated wells was achieved by preincubating the sera with 5 p.g gpl60r~ for 30 rain before adding the mixture to the wells.
Results

Characterization o f HIV-specific M A b s
Two M A b s directed against HIV-1 were selected after fusion. By I F assays, M A b s gp41-1 (IgG2a, r) and gp41-2 (IgG1, r) showed reactivity with HIV-1 H T L V -I I I B , LAV-1 and R F strains, a n d no reactivity with HIV-2 ROD-infected cells. Both M A b s recognized the 41K t r a n s m e m b r a n e portion of the envelope glycoprotein a n d a 160K r e c o m b i n a n t HIV-1 envelope glycoprotein (gpl60rec), as d e t e r m i n e d by Western blotting (Fig. 1) . gpl60ree was also recognized by both M A b s in E L I S A ; absorbances of 1.5 and 1.8 were observed w h e n 0.1 ~tg of gp41-1 and gp41-2 was used. R I P A showed that both M A b s were also efficient at i m m u n o p r e c i p i t a t i n g the gp41 precursor, gpl60, from HIV-1 infected cells. In a neutralization assay using the HIV-1 H T L V -I I I B strain, M A b s caused a reduction of R T activity ( 5 0~ reduction).
To characterize further the epitope recognized by both MAbs, surface I F assays were performed. Positive staining of viable H I V -l -i n f e c t e d H U T -7 8 cells was observed. Confirmation that the epitope was surface 
Production o f anti-ids
M A b gp41-1 was used to generate syngeneic monoclonal anti-ids because I g G 2 a a n t i b o d y molecules can easily be cleaved into F(ab')2 fragments (Parham, 1983) . The presence of anti-ids in sera from gp41-1-immunized mice and hybridoma culture supernatants was tested by ELISA using plates coated with gp41-1 F(ab')2 fragments. Anti-ids were detected in sera from mice immunized with gp41-1-KLH. In contrast, no antibody binding was observed using sera from non-immune and KLH-immunized mice. Mice showing high anti-id titres (1/32000) were chosen for subsequent fusion of their spleen cells. Six anti-ids were selected from one fusion experiment, MAbs agp41-11,-14, -15, -16, which were lgGl x, and agp41-12 and -13 were lgG2a x. The specificity of anti-ids for gp41-1 was assessed in ELISA by a direct binding assay of anti-ids to F(ab')2 fragments from an irrelevant IgG2a MAb, Hb-2. Results showed that none of the anti-ids reacted with the irrelevant IgG2a whereas positive binding was observed with gp41-1 F(ab')z (Table 1) . IF assays showed that antiids did not react with HIV-l-infected or uninfected HUT-78 cells.
MAbs gp41-1 and gp41-2 were biotinylated in order to study their direct binding to plates coated with anti-ids; both MAbs reacted with all of the anti-ids. The ability of anti-ids to inhibit the binding of biotinylated gp41-1 to plate-bound anti-id was investigated to determine whether the anti-ids recognized different idiotopes. Results from these experiments allowed the division of the anti-ids into three groups (Table 2) . Anti-id agp41-11 (group 1) inhibited the binding of gp41-1 to homologous agp41-11 but not to other immobilized anti-ids. In contrast, agp41-12 (group 2) inhibited the binding of gp41-1 to all anti-ids except agp41-11. Agp41-13 to -16 (group 3) each prevented the binding of gp41-1 to other immobilized group 3 anti-ids and had no effect on the binding ofgp41-1 to agp41-11 and -12 coated wells, with the exception of agp41-15 which partially inhibited the binding of gp41-1 to immobilized agp41-11, gp41-1 inhibited the binding of biotinylated gp41-1 to all six anti-ids. The presence of two unrelated anti-ids, AHb-22 and AHb-24, had no effect on gp41-1-anti-id interaction.
To ascertain whether or not the idiotopes recognized by our anti-ids were present on isolated heavy or light chains, immunoblotting experiments were conducted using gp41-1 treated or not treated with 2-mercaptoethanol before migration and transfer to nitrocellulose membrane. None of the anti-ids recognized isolated heavy or light chains but all six reacted strongly when gp41-1 was not reduced.
Attempts were made to determine whether anti-ids could inhibit the binding of MAbs gp41-1 and gp41-2 to their viral antigen (Fig. 2) . All anti-ids inhibited gp41-1 binding to HIV-l-infected cell lysates and were also efficient at inhibiting gp41-2 binding to HIV-infected cell lysates, except for agp41-12 which did not inhibit binding; percentage inhibition varied between 70 and 97% (Fig. 2a) . Control antibodies NG38 and AHb-22 had no effect on binding of gp41-1 or gp41-2 to antigen. * Biotinylated MAb gp41-1 was preincubated with 5 p~g anti-id, used as competitor. The mixture was then added to wells coated with anti-id and the inhibition of binding of gp41-1 to anti-id was determined.
t +, Over 70~ inhibition; +/-, 60% inhibition; -, less than 30~ inhibition. BALB/c mice and six rabbits were injected with a constant dose of anti-id and their sera were assayed for anti-gpl60 activity by ELISA. None of the mice that were immunized with anti-id coupled to KLH showed significant anti-gpl60 reactivity compared to that observed with preimmune sera. However, an anti-gp 160 antibody response was detected in the sera of rabbits immunized with anti-ids agp41-11 and agp41-13 (Fig. 3) . These sera showed five-to sixfold greater reactivity with gpl60rec in ELISA than the preimmune sera. The binding of rabbit anti-anti-id to gp 160rec was inhibited in a dose-dependent manner by preincubation with soluble gpl60re¢ (data not shown). In addition, immunoblotting experiments showed that sera from rabbits immunized with agp41-11 and agp41-13 had the same pattern of reactivity as MAb gp41-1 had for gpl60re¢ (Fig. 4) . Antibodies against gpl60r~ were not detected in the sera of rabbits immunized with agp41-12, agp41-14, agp41-15, agp41-16 or control anti-id AHb-21.
Discussion
The development of a vaccine for HIV presents major difficulties. In addition to the high degree of genetic variability among isolates, HIV infection may be transmitted as either free or cell-associated virus. Thus, an effective vaccine may have to be capable of inducing neutralizing and/or cytotoxic antibodies along with cellmediated immunity. Anti-id vaccines represent a new approach to the stimulation of protective immunity against HIV as they are able to induce B as well as T cell immunity (Hiernaux, 1988) . In this report we describe anti-ids that were generated against HIV-specific MAbs. We initially isolated two MAbs that recognized gp 160 in RIPA and ELISA, and both gpl60 and gp41 in immunoblot analysis. These MAbs reacted with surfaceexposed epitopes on HIV-l-infected cells. They also reacted with well conserved epitopes on gp41 because they recognized the HIV-1 RF strain, an isolate divergent from the immunizing HTLV-IIIB strain (Starcich et al., 1986; Myers et al., 1989) and did not react with HIV-2. Such conserved regions of gp41 had been already identified using synthetic peptides corresponding to residues 598 to 609 (Gnann et al., 1987a) and 735 to 752 (Kennedy et al., 1986b) . Much evidence suggests that these regions are exposed at the surface of the virus (Chanh et al., 1986; Gnann et al., 1987b) and rabbit antisera and murine MAbs generated to the latter peptide neutralized HIV-1 and not HIV-2 infectivity in vitro (Chanh et al., 1986; Dalgleish et al., 1988) . However, Zhou et al. (1987) also reported that chimpanzee antisera to this peptide failed to neutralize HIV infectivity in vitro. Whether or not our MAbs recognized epitopes corresponding to those synthetic peptides remains to be defined. MAb gp41-1 was selected for the production of antiids and six anti-ids defining at least three distinct idiotopes were characterized. According to Jerne (1984) , different classes of anti-ids may be distinguished: the Ab2~ family recognizes an idiotope not associated with the antigen-combining site (paratope), whereas the Ab2fl family, also referred to as an internal image anti-id, recognizes a paratope-related idiotope. Ab2),, which is an Ab2~ subfamily, recognizes idiotypes closely associated with the paratope and interferes with the binding of the first antibody with its antigen. Zhou et al. (1990) reported the generation of a murine anti-id (MC1) directed against chimpanzee immunoglobulins specific to a synthetic peptide (residues 735 to 752) of gp41. The gp41-1-anti-id binding could not be inhibited by gp41 peptide and the anti-id could not inhibit the binding of gp41-1 to the gp41 peptide. Furthermore, immunization of animals with anti-id MC1 showed that an anti-gpl60 response could be generated in syngeneic mice but not in rabbits. These results suggested that MC1 was probably of the Ab2~ type. The use of Ab2~ as a vaccine candidate is restricted due to the family's inability to induce an antigen-positive response across the species barrier, although their role in modulating the expression of silent clones has been documented (Bona et al., 1981 ; Hiernaux et al., 1981) . Ab2fl anti-ids, which can induce an antigenpositive response across the species barrier, have greater potential for vaccine development (Hiernaux, 1988) .
Experiments were performed to characterize our antiids as Ab2~ or Ab2fl. lmrnunoblotting of MAb gp41-1 using anti-ids showed that idiotopes resulted from the association of both heavy and light chains. These findings suggested that the anti-ids recognized paratopeassociated idiotopes because, in most cases, the binding of an antibody to its antigen involves amino acid residues on both Ig chains (Amit et al., 1986) . The presence of anti-id prevented the binding of MAb gp41-1 to its antigen, an additional indication that the idiotopes are associated with the paratope. In addition, all our anti-ids except for agp41-12 prevented the binding of gp41-2 to its antigen and both gp41-1 and gp41-2 MAbs reacted with immobilized anti-ids. Together, these results suggest that gp41-1 and gp41-2 share common idiotopes. Based on the reactivity of these MAbs with different antigenic preparations, there is no indication that gp41-1 (IgG2a) and gp41-2 (IgG1) recognized distinct epitopes. The discrepancies between results obtained with these MAbs may be explained by differences in their affinity for the antigen and/or the anti-ids.
Although anti-id-binding inhibition of gp41-1 to its antigen suggested that the anti-ids were of the Ab213 family, the induction of an antigen-specific immune response by anti-id in animals which have never encountered the antigen is an essential criterion to distinguish Ab2fl from Ab2~ or Ab27. In vivo administration of anti-id agp41-11 and -13 induced specific antigpl60re c immune responses in rabbits. On the basis of these data, it appeared that both agp41-11 and agp41-13, which probably defined distinct idiotopes, were Ab2fl internal image anti-ids whereas other anti-ids were Ab2% Studies are in progress to optimize the parameters influencing the appearance of antigen-specific anti-antiids in order better to define the potential use of anti-ids as modulators of the immune response to infectious agents.
